Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
08/30/2000 | CN1264586A Compound Chinese medicine for treating hepatocholepathy |
08/30/2000 | CN1264585A Exterior-applied Chinese-medicinal liniment for treating alopecia areata, seborrheic alopecia and bald |
08/30/2000 | CN1264584A Medicine for treating craniocerebral trauma andintracranial hematoma and its preparing process |
08/30/2000 | CN1055863C Health-care defatting products and its prepn. thereof |
08/30/2000 | CN1055862C Chinese medicine prepn. for curing osteonescrosis |
08/30/2000 | CN1055860C Wine for curing bone impediment and rheumatic pain |
08/30/2000 | CN1055858C Medicine for toothache |
08/30/2000 | CN1055857C Chinese drugs for darkening hair and its prepn. method |
08/30/2000 | CN1055855C Eexternal-use medicine for curing scars |
08/30/2000 | CN1055853C Chiense drug for treating osteoporosis |
08/30/2000 | CN1055847C Medicine for curing deficiency of liver and kidney and its prodn. method |
08/30/2000 | CN1055843C Method for prepn. of medicine for treating aplastic anemia |
08/30/2000 | CN1055840C Prepn. for treating coronary hart disease |
08/30/2000 | CN1055839C Prepn. for treating cancer and its preparing process |
08/30/2000 | CN1055837C Chinese medicine for treating blood vessel dementia |
08/30/2000 | CN1055836C Fresh-juice Tianmami (gastrodia tuber sweet) health care food and making method thereof |
08/30/2000 | CN1055832C Capsule of cartilage powder of shark and prepn. thereof |
08/29/2000 | USRE36844 Cellular attachment to trans-epithelial appliances |
08/29/2000 | US6110899 LICC of Streptococcus pneumoniae |
08/29/2000 | US6110743 Vector having at least two oncogenes, a pair of genetic elements which are recombination sites flanking the oncogenes, and another gene; for transformed cells which produce insulin and can be transplanted into human diabetic patients |
08/29/2000 | US6110741 Gonadotrophin releasor hormone-containing composition for embryo culture and method for in vitro fertilization |
08/29/2000 | US6110739 Producing immortalized cell population by transforming embryonic stem cell population with immortalizing gene, culturing, incubating to obtain cell population that differentiates into primitive and definitive erythroid cells |
08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
08/29/2000 | US6110688 Separating compounds from human urine; freezing human urine, thawing urine, separating precipitate by centrifuging, recovering precipitate, dissolvingin solution, dialysis, separating supernatant, isolate protein, detect with antibody |
08/29/2000 | US6110672 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
08/29/2000 | US6110504 A crystalloid solution consisting of dissolved salts comprising sodium chloride, potassium chloride, calcium chloride, magnesium chloride and organic acid selected from lactate, acetate, pyruvate, gluconate, succinate, and glucose |
08/29/2000 | US6110487 Method of making porous keratin scaffolds and products of same |
08/29/2000 | US6110463 Anti-Cryptosporidium parvum preparations |
08/29/2000 | US6110461 Reovirus for the treatment of neoplasia |
08/29/2000 | US6110460 Methods of using morphogen analogs |
08/29/2000 | US6110459 Grafting of myocardium tissues |
08/29/2000 | US6110458 Cancer therapy utilizing ex vivo gene transduction |
08/29/2000 | US6110455 Method for encouraging poultry to distribute and ingest competitive exclusion products |
08/29/2000 | US6110209 Method and paste for articular cartilage transplantation |
08/29/2000 | US6110208 Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives |
08/24/2000 | WO2000049168A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
08/24/2000 | WO2000049162A2 Compositions and methods for non-targeted activation of endogenous genes |
08/24/2000 | WO2000049141A2 A method for production and delivery of a protein in vivo |
08/24/2000 | WO2000049138A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of stomatic cells |
08/24/2000 | WO2000049137A2 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
08/24/2000 | WO2000049136A1 Genetically altered mesenchymal stem cells and methods of use thereof |
08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
08/24/2000 | WO2000048624A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
08/24/2000 | WO2000048615A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
08/24/2000 | WO2000048614A2 Method for producing anti-tumor th1 cells |
08/24/2000 | WO2000048462A1 Method for inhibiting transplant rejection |
08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
08/24/2000 | WO2000029550A3 Low oxygen culturing of central nervous system progenitor cells |
08/24/2000 | WO2000023571A3 A method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
08/24/2000 | WO2000016800A9 Methods of treating chronic pain |
08/24/2000 | DE19906744A1 Pharmaceutical composition useful for tumor therapy comprises tumor-reactive helper T cells that produce high levels of interferon gamma and little or no interleukin-4 |
08/24/2000 | CA2645398A1 Universal plasma from antibodies-depleted blood |
08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
08/24/2000 | CA2364267A1 Compositions and methods for non-targeted activation of endogenous genes |
08/24/2000 | CA2363063A1 Helper dependent adenovirus vectors based on site-specific recombinases |
08/24/2000 | CA2362664A1 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
08/24/2000 | CA2362161A1 Method for inhibiting transplant rejection |
08/24/2000 | CA2361925A1 Treatment of chronic viral infections with m. vaccae |
08/23/2000 | EP1029068A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
08/23/2000 | EP1029062A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
08/23/2000 | EP1029035A1 Method for inducing osteoblast differentiation of human extramedullary adipose tissue cells |
08/23/2000 | EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
08/23/2000 | EP1028754A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
08/23/2000 | EP1028743A1 TREATMENT AND DIAGNOSIS OF INFERTILITY USING TGF$g(b) OR ACTIVIN |
08/23/2000 | EP1028738A1 Use of cytokines and mitogens to inhibit pathological immune responses |
08/23/2000 | EP1028626A1 Method for the augmentation of gene expression |
08/23/2000 | EP0686039B1 Method of enhancing immune response to oral vaccines |
08/23/2000 | EP0666771B1 Apparatus for separating blood components with controlled anticoagulant dosage |
08/23/2000 | CN1264422A Immunity enhancing lactic acid bacteria |
08/23/2000 | CN1264305A Oral care composition comprising bacillus pullulanase and dextranase |
08/23/2000 | CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use |
08/23/2000 | CN1263771A Black plaster and preparing process thereof |
08/23/2000 | CN1263770A Thrombolytic medicine and its preparing process |
08/23/2000 | CN1055639C Health-care medicine |
08/23/2000 | CN1055638C Selenium-riched Chinese caterpillar fungus oral liquor and its prepn. method |
08/23/2000 | CN1055637C Medicine for treatment of mammary gland disease and method for producing thereof |
08/23/2000 | CN1055635C Smoking stopping powder |
08/23/2000 | CN1055629C Making up method for medicinal liquid of ice guide therapeutic method on channels and acupuncture point |
08/23/2000 | CN1055626C Orally traditional Chinese medicine for orthopedics disease |
08/23/2000 | CN1055624C Scorpion-and-ant oral liquid and its preparation method |
08/22/2000 | USRE36831 Iron-pyridone complexes for anemia |
08/22/2000 | US6107520 Spisulosine compounds |
08/22/2000 | US6107457 Bcr-abl peptide having tyrosine from position 177 and/or tyrosine from position 283; suppresses induction of ras protein; anticarcinogenic agents for leukemia; enriching bone marrow stem cells prior to transplantation |
08/22/2000 | US6107028 Prevention of viral replication or expression; insertion of a expression vector coding ribonucleic acid preferential proteolytic enzyme into cells infected with virus |
08/22/2000 | US6107027 Supression of viral gene expression in cells; transducing cells with a adenovirus vector which codes a protein which has preferential proteolytic activity for ribonucleic acids |
08/22/2000 | US6106867 Gelatinized propolis food products |
08/22/2000 | US6106846 Topically applying to treat neurogenic inflammation |
08/22/2000 | US6106832 Treating x-linked hyper igm syndrome and combined variable immunodeficiency syndrome |
08/22/2000 | US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin |
08/17/2000 | WO2000047762A2 Enriched central nervous system cell populations |
08/17/2000 | WO2000047757A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
08/17/2000 | WO2000047720A2 Pancreatic progenitor cells, methods and uses related thereto |
08/17/2000 | WO2000047719A2 Maturation of dendritic cells with immune response modifying compounds |